韩国股骨髋臼撞击的流行病学。

IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Dong-Hoon Lee, Ki-Tae Park, Jonghwa Won, Joon Hwan An, Jung-Wee Park, Young-Kyun Lee
{"title":"韩国股骨髋臼撞击的流行病学。","authors":"Dong-Hoon Lee, Ki-Tae Park, Jonghwa Won, Joon Hwan An, Jung-Wee Park, Young-Kyun Lee","doi":"10.3346/jkms.2025.40.e124","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Femoroacetabular impingement (FAI) is increasingly recognized as a significant cause of hip and groin pain. Despite the rising awareness, epidemiological data on FAI remain limited in East Asia. This study aimed to investigate the prevalence, treatment patterns, and associated medical costs of FAI in South Korea.</p><p><strong>Methods: </strong>To identify patients with FAI, a nationwide claims database from the Korean Health Insurance Review and Assessment Service (HIRA) was used from January 2013 to December 2022. The patients were identified using the International Classification of Diseases, 10th Revision codes for FAI. Patients aged 15 years and older were grouped into 5-year age intervals and categorized according to gender. The overall crude and age-adjusted prevalence were assessed from 2013 to 2022 using the Korean Statistical Information Service (KOSIS). Patients were further categorized into those undergoing surgical treatment and conservative treatments. To assess the economic burden of the disease, we estimated the total medical and out-of-pocket costs reimbursed for patients diagnosed with these codes.</p><p><strong>Results: </strong>During the study period, 39,620 patients were considered to have the diagnosis of FAI. Among them, 2,884 patients were hospitalized, including 1,562 men and 1,322 women. The number of hospitalized patients slightly decreased from 303 in 2013 to 281 in 2022. However, the total number of patients increased significantly from 2,721 in 2013 to 5,196 in 2022. When stratified by age in 5-year intervals, a bimodal distribution was observed for men and an unimodal distribution for women, with a peak in the 50s. The age-adjusted prevalence showed an annual increase of 7.14% (95% confidence interval [CI], 4.56-10.22; <i>P</i> < 0.001), rising from 5.94 per 100,000 (95% CI, 5.70-6.17) to 10.40 per 100,000 (95% CI, 10.11-10.68). Despite rising overall patient numbers, the proportion undergoing surgical treatment declined from 11.1% to 5.4%. Total medical costs increased by 43% for men and 27% for women from 2013 to 2022.</p><p><strong>Conclusion: </strong>This study highlights the significant increase in FAI prevalence and related healthcare costs in South Korea. However, only a minority of FAI patients underwent surgical treatment during the study period.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 25","pages":"e124"},"PeriodicalIF":3.0000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209539/pdf/","citationCount":"0","resultStr":"{\"title\":\"Epidemiology of Femoroacetabular Impingement in Korea.\",\"authors\":\"Dong-Hoon Lee, Ki-Tae Park, Jonghwa Won, Joon Hwan An, Jung-Wee Park, Young-Kyun Lee\",\"doi\":\"10.3346/jkms.2025.40.e124\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Femoroacetabular impingement (FAI) is increasingly recognized as a significant cause of hip and groin pain. Despite the rising awareness, epidemiological data on FAI remain limited in East Asia. This study aimed to investigate the prevalence, treatment patterns, and associated medical costs of FAI in South Korea.</p><p><strong>Methods: </strong>To identify patients with FAI, a nationwide claims database from the Korean Health Insurance Review and Assessment Service (HIRA) was used from January 2013 to December 2022. The patients were identified using the International Classification of Diseases, 10th Revision codes for FAI. Patients aged 15 years and older were grouped into 5-year age intervals and categorized according to gender. The overall crude and age-adjusted prevalence were assessed from 2013 to 2022 using the Korean Statistical Information Service (KOSIS). Patients were further categorized into those undergoing surgical treatment and conservative treatments. To assess the economic burden of the disease, we estimated the total medical and out-of-pocket costs reimbursed for patients diagnosed with these codes.</p><p><strong>Results: </strong>During the study period, 39,620 patients were considered to have the diagnosis of FAI. Among them, 2,884 patients were hospitalized, including 1,562 men and 1,322 women. The number of hospitalized patients slightly decreased from 303 in 2013 to 281 in 2022. However, the total number of patients increased significantly from 2,721 in 2013 to 5,196 in 2022. When stratified by age in 5-year intervals, a bimodal distribution was observed for men and an unimodal distribution for women, with a peak in the 50s. The age-adjusted prevalence showed an annual increase of 7.14% (95% confidence interval [CI], 4.56-10.22; <i>P</i> < 0.001), rising from 5.94 per 100,000 (95% CI, 5.70-6.17) to 10.40 per 100,000 (95% CI, 10.11-10.68). Despite rising overall patient numbers, the proportion undergoing surgical treatment declined from 11.1% to 5.4%. Total medical costs increased by 43% for men and 27% for women from 2013 to 2022.</p><p><strong>Conclusion: </strong>This study highlights the significant increase in FAI prevalence and related healthcare costs in South Korea. However, only a minority of FAI patients underwent surgical treatment during the study period.</p>\",\"PeriodicalId\":16249,\"journal\":{\"name\":\"Journal of Korean Medical Science\",\"volume\":\"40 25\",\"pages\":\"e124\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209539/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Korean Medical Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3346/jkms.2025.40.e124\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Korean Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3346/jkms.2025.40.e124","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:股髋臼撞击(FAI)越来越被认为是髋关节和腹股沟疼痛的重要原因。尽管认识不断提高,但东亚地区关于急性呼吸道感染的流行病学数据仍然有限。本研究旨在调查韩国FAI的患病率、治疗模式和相关医疗费用。方法:为了识别FAI患者,从2013年1月到2022年12月,使用了韩国健康保险审查和评估服务(HIRA)的全国索赔数据库。使用国际疾病分类第10版FAI代码对患者进行鉴定。年龄在15岁及以上的患者按性别分为5年一组。使用韩国统计信息服务(KOSIS)评估了2013年至2022年的总体粗糙患病率和年龄调整患病率。患者进一步分为手术治疗组和保守治疗组。为了评估这种疾病的经济负担,我们估计了诊断为这些代码的患者的总医疗费用和自付费用。结果:在研究期间,39,620例患者被认为诊断为FAI。其中住院患者2,884人,其中男性1,562人,女性1,322人。住院患者从2013年的303人略微减少到2022年的281人。然而,患者总数从2013年的2721人大幅增加到2022年的5196人。当以5年为间隔按年龄分层时,观察到男性为双峰分布,女性为单峰分布,在50多岁时达到峰值。年龄调整后的患病率每年增加7.14%(95%可信区间[CI], 4.56-10.22;P < 0.001),从5.94 / 100,000 (95% CI, 5.70-6.17)上升到10.40 / 100,000 (95% CI, 10.11-10.68)。尽管总体患者人数上升,但接受手术治疗的比例从11.1%下降到5.4%。从2013年到2022年,男性的总医疗费用增加了43%,女性增加了27%。结论:本研究强调了韩国FAI患病率和相关医疗费用的显著增加。然而,在研究期间,只有少数FAI患者接受了手术治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Epidemiology of Femoroacetabular Impingement in Korea.

Background: Femoroacetabular impingement (FAI) is increasingly recognized as a significant cause of hip and groin pain. Despite the rising awareness, epidemiological data on FAI remain limited in East Asia. This study aimed to investigate the prevalence, treatment patterns, and associated medical costs of FAI in South Korea.

Methods: To identify patients with FAI, a nationwide claims database from the Korean Health Insurance Review and Assessment Service (HIRA) was used from January 2013 to December 2022. The patients were identified using the International Classification of Diseases, 10th Revision codes for FAI. Patients aged 15 years and older were grouped into 5-year age intervals and categorized according to gender. The overall crude and age-adjusted prevalence were assessed from 2013 to 2022 using the Korean Statistical Information Service (KOSIS). Patients were further categorized into those undergoing surgical treatment and conservative treatments. To assess the economic burden of the disease, we estimated the total medical and out-of-pocket costs reimbursed for patients diagnosed with these codes.

Results: During the study period, 39,620 patients were considered to have the diagnosis of FAI. Among them, 2,884 patients were hospitalized, including 1,562 men and 1,322 women. The number of hospitalized patients slightly decreased from 303 in 2013 to 281 in 2022. However, the total number of patients increased significantly from 2,721 in 2013 to 5,196 in 2022. When stratified by age in 5-year intervals, a bimodal distribution was observed for men and an unimodal distribution for women, with a peak in the 50s. The age-adjusted prevalence showed an annual increase of 7.14% (95% confidence interval [CI], 4.56-10.22; P < 0.001), rising from 5.94 per 100,000 (95% CI, 5.70-6.17) to 10.40 per 100,000 (95% CI, 10.11-10.68). Despite rising overall patient numbers, the proportion undergoing surgical treatment declined from 11.1% to 5.4%. Total medical costs increased by 43% for men and 27% for women from 2013 to 2022.

Conclusion: This study highlights the significant increase in FAI prevalence and related healthcare costs in South Korea. However, only a minority of FAI patients underwent surgical treatment during the study period.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Korean Medical Science
Journal of Korean Medical Science 医学-医学:内科
CiteScore
7.80
自引率
8.90%
发文量
320
审稿时长
3-6 weeks
期刊介绍: The Journal of Korean Medical Science (JKMS) is an international, peer-reviewed Open Access journal of medicine published weekly in English. The Journal’s publisher is the Korean Academy of Medical Sciences (KAMS), Korean Medical Association (KMA). JKMS aims to publish evidence-based, scientific research articles from various disciplines of the medical sciences. The Journal welcomes articles of general interest to medical researchers especially when they contain original information. Articles on the clinical evaluation of drugs and other therapies, epidemiologic studies of the general population, studies on pathogenic organisms and toxic materials, and the toxicities and adverse effects of therapeutics are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信